A Phase 1 trial testing TG Therapeutics' CAR T-cell therapy azer-cel in progressive forms of MS is now recruiting across ...

UCLA scientists have developed a next-generation CAR-T cell therapy that can overcome the immunosuppressive tumor ...

A new, highly sensitive cell therapy was able to wipe out three different kinds of solid tumors in mice, an important advance ...

In an analysis of therapeutic interventions following the failure of chimeric antigen receptor (CAR) T-cell therapy, Rahul ...

A proof-of-concept study opens up an avenue for treating solid tumours that express low levels of a target antigen.

Renier Brentjens, MD, PhD, one of the pioneers in the development of chimeric antigen receptor (CAR) T-cell therapy, is poised to see the technology take its next big leap, with researchers testing ...

Researchers hope to undertake clinical studies in multiple cancers, including ovarian cancer, glioblastoma, and others.